Figure 2 | Scientific Reports

Figure 2

From: Suppression of BCL6 function by HDAC inhibitor mediated acetylation and chromatin modification enhances BET inhibitor effects in B-cell lymphoma cells

Figure 2

BCL2 family protein expression upon romidepsin treatment. Western blot showing BCL2 (a), BCL-xL (b), MCL1 (c) and BIM (d) protein expression in B-cell lymphoma cells treated with 2 or 5 nM romidepsin for the indicated times. Actin or GAPDH were used as loading controls. Densitometry values are shown at the bottom, normalized to the control. The blots were cropped for improved clarity and the full-length blots were included in the Supplementary Information file.

Back to article page